Federal contract award
75H70625F03064
PRE- PRICED BLANKET PURCHASE CALL NO. 75H70625F03064 TO PROVIDE COST PER REPORTABLE HEMATOLOGY CHEMISTRY TESTING FOR THE PINE RIDGE INDIAN HEALTH SERVICE HOSPITAL. THE PERIOD OF PERFORMANCE WILL BE JANUARY 1, 2025 THROUGH FEBRUARY 28, 2025.
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | GREAT PLAINS AREA INDIAN HEALTH SVC |
| NAICS | 334516 — Analytical Laboratory Instrument Manufacturing |
| PSC | W065 — Lease or Rental of Equipment: Medical, Dental, and Veterinary Equipment and Supplies |
| Parent award / vehicle | 75H70621A00010 |
| Set-aside | Not reported |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $22.8K |
| Current contract value | $22.8K |
| Potential contract value / ceiling | $22.8K |
| Start date | Dec 31, 2024 |
| Current end date | Feb 28, 2025 |
| Potential end date | Jan 19, 2026 |
| Latest award activity | Jan 16, 2026 |
| Source loaded | Sep 19, 2026 |
Funding and modification history
Showing the latest 2 of 2 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jan 16, 2026 | P00001 | $-3.2K | MODIFICATION NO. ONE TO DE-OBLIGATE BPA CALL NO. 75H70625F03064 EXCESS FUNDS THAT PROVIDED COST PER REPORTABLE HEMATOLOGY CHEMISTRY TESTING FOR THE PINE RIDGE INDIAN HEALTH SERVICE HOSPITAL. THE VENDOR APPROVED THE DE-OBLIGATION VIA EMAIL ON 01/14/20 |
| Dec 31, 2024 | 0 | $26.0K | PRE- PRICED BLANKET PURCHASE CALL NO. 75H70625F03064 TO PROVIDE COST PER REPORTABLE HEMATOLOGY CHEMISTRY TESTING FOR THE PINE RIDGE INDIAN HEALTH SERVICE HOSPITAL. THE PERIOD OF PERFORMANCE WILL BE JANUARY 1, 2025 THROUGH FEBRUARY 28, 2025. |
Research next steps
- Verify whether remaining options may extend performance beyond the current end date.
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.